Last reviewed · How we verify
Desvenlafaxine succinate 50mg
Desvenlafaxine succinate 50mg is a Small molecule drug developed by Seoul National University Hospital. It is currently FDA-approved.
At a glance
| Generic name | Desvenlafaxine succinate 50mg |
|---|---|
| Sponsor | Seoul National University Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study of Desvenlafaxine in Treating Major Depressive Disorder. (PHASE3)
- Dimensional Approach to Evaluate Reward Processing in Major Depressive Disorder Pre- and Post-Desvenlafaxine Treatment (PHASE4)
- Efficacy of SNRI Treatment on Prefrontality in Patients With GAD and Other Comorbities (PHASE4)
- Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen (PHASE4)
- Omega 3 FA Supplements as Augmentation in the Treatment of Depression (PHASE2, PHASE3)
- Safety, Tolerability and Pharmacokinetics Study of LY03005 (PHASE1)
- Desvenlafaxine Monotherapy in Dysthymia (NA)
- Paroxetine-referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDD (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Desvenlafaxine succinate 50mg CI brief — competitive landscape report
- Desvenlafaxine succinate 50mg updates RSS · CI watch RSS
- Seoul National University Hospital portfolio CI
Frequently asked questions about Desvenlafaxine succinate 50mg
What is Desvenlafaxine succinate 50mg?
Desvenlafaxine succinate 50mg is a Small molecule drug developed by Seoul National University Hospital.
Who makes Desvenlafaxine succinate 50mg?
Desvenlafaxine succinate 50mg is developed and marketed by Seoul National University Hospital (see full Seoul National University Hospital pipeline at /company/seoul-national-university-hospital).
What development phase is Desvenlafaxine succinate 50mg in?
Desvenlafaxine succinate 50mg is FDA-approved (marketed).